Stockholders of Alexion Pharmaceuticals Inc. approved a two-for-one split of the Cheshire drug maker’s stock.
The clear way stockholders voting at Alexion’s annual meeting Thursday in New Haven authorized doubling to 290 million the number of shares outstanding, the company announced.
The extra shares will be distributed as a dividend at the close of business May 20 to stockholders of record as of May 2.
Reporting of the Alexion share price on a split-adjusted basis will start May 23.
ADVERTISEMENT
In late morning trading Thursday, Alexion was down 28 cents to $98.58.
